Schedule 13G filing

AdvisorShares Trust disclosed a 6.8% stake in Psyence Biomedical Ltd. (PBM)

Schedule 13G · Filed Oct 5, 2026

AdvisorShares Trust reported owning 6.8% of Psyence Biomedical Ltd. (PBM) (258,538 shares) in a Schedule 13G filed Oct 5, 2026.

A 13G is a passive stake: the holder does not plan to push for changes.

Stake

Psyence Biomedical Ltd.

Stake

6.8% stake

Share this trade

From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.